Compounds > cyclopentane
Page last updated: 2024-08-21

cyclopentane and Carcinoma, Non-Small Cell Lung

cyclopentane has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Buachan, P; Namsa-Aid, M; Peng, C; Sung, HK; Sweeney, G; Tanechpongtamb, W1
Fan, S; Jiang, Z; Liao, Y; Liu, C; Tang, H; Wang, J; Xiong, J; Zhou, B; Zhou, S; Zou, M1
Guo, ZP; Hu, YC; Jin, F; Liu, XD; Ma, T; Song, ZQ; Xie, Y; Zhou, PK1
Barrand, MA; Rhodes, T; Twentyman, PR1

Other Studies

4 other study(ies) available for cyclopentane and Carcinoma, Non-Small Cell Lung

ArticleYear
Inhibitory effects of terrein on lung cancer cell metastasis and angiogenesis.
    Oncology reports, 2021, Volume: 45, Issue:6

    Topics: A549 Cells; Animals; Aspergillus; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Chlorocebus aethiops; Cyclopentanes; Humans; Lung Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vero Cells

2021
G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:4

    Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Blotting, Western; Carcinogens; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Cell Proliferation; Cyclopentanes; Disease Progression; Estradiol; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Middle Aged; Neoplasm Staging; Phosphorylation; Prognosis; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA, Small Interfering; Tissue Array Analysis; Tumor Cells, Cultured; Urethane; Xenograft Model Antitumor Assays

2015
MLN4924 suppresses the BRCA1 complex and synergizes with PARP inhibition in NSCLC cells.
    Biochemical and biophysical research communications, 2017, 01-29, Volume: 483, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Line, Tumor; Cyclopentanes; DNA Damage; DNA-Binding Proteins; Histone Chaperones; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Multiprotein Complexes; NEDD8 Protein; Nuclear Proteins; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Pyrimidines; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Ubiquitins

2017
Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
    British journal of cancer, 1994, Volume: 70, Issue:1

    Topics: 4-Chloro-7-nitrobenzofurazan; Anti-Bacterial Agents; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brefeldin A; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Nucleus; Cyclopentanes; Cytoplasm; Daunorubicin; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Golgi Apparatus; Humans; Lung Neoplasms; Macrolides; Membrane Glycoproteins; Protein Synthesis Inhibitors; Proton-Translocating ATPases; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured

1994